UPDATE: Northland Capital Markets Upgrades Insulet Corporation (PODD) to Outperform

Northland Capital Markets upgraded Insulet Corporation (NASDAQ: PODD) from Market Perform to Outperform with a price target of $32. Analyst Suraj Kalia sees short-term risk to numbers but he is positive overall given recent under-performance.

"Overall, we are getting constructive on the name, despite short-term risk to numbers. The stock is off almost 50% from its highs & could be weak going into Q2. Our rationale is a reflection of recent stock compression, and high takeout multiples in the diabetes space," said Kalia.

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $26.97 yesterday.

You May Also Be Interested In

• RBC Capital Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Outperform
• B.Riley Upgrades The Children's Place (PLCE) to Neutral
• Piper Sandler Upgrades SmartFinancial (SMBK) to Overweight 'on Risk/Reward Dynamic for Clean Bank Under TBVPS'